Article: Prostate Cancer - Hormone-Refractory Patients Still Waiting for Treatment Breakthroughs.

NEW YORK -- Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

Stakeholder Insight: Prostate Cancer - Hormone-refractory patients still waiting for treatment breakthroughs

To order that report:

www.reportlinker.com/p073694/Stakeholder-Insight-Prostate -Cancer---Hormone-refractory-patients -still-waiting-for-treatment-breakthroughs.html

For more information, contact Nicolas by email nbo@reportlinker.com , by phone +33 4 37 65 17 03.

As a result of market dominance by agents such as leuprolide, and AstraZeneca's Zoladex (goserelin) and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!